Literature DB >> 28956088

Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin.

Reinier Smit1, Rob J van Marum2,3, Nathalie C Péquériaux4, Daan A Hollander5, Michiel W P Bleeker6, Yasamin Latify7, Walter A Hermens1, Hieronymus J Derijks1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28956088     DOI： 10.1007/s00228-017-2339-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Authors:  Wendy Lim; Francesco Dentali; John W Eikelboom; Mark A Crowther
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

2.  Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.

Authors:  Christoph Hammerstingl; Heyder Omran
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

Review 3.  Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.

Authors:  Edith A Nutescu; Sarah A Spinler; Ann Wittkowsky; William E Dager
Journal:  Ann Pharmacother       Date:  2009-05-19       Impact factor: 3.154

Review 4.  A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency.

Authors:  Ferdows Atiq; Patricia M L A van den Bemt; Frank W G Leebeek; Teun van Gelder; Jorie Versmissen
Journal:  Eur J Clin Pharmacol       Date:  2015-06-14       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.